tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TSE:TTI Stock Latest News

Thiogenesis Advances Cystinosis Program With New Study and Phase 3 Plans for TTI-0102
Company AnnouncementsThiogenesis Advances Cystinosis Program With New Study and Phase 3 Plans for TTI-0102
4d ago
Thiogenesis Posts Positive Phase 2 MELAS Data, Backs Weight-Based Dosing for Lead Mitochondrial Drug
PremiumCompany Announcements
Thiogenesis Posts Positive Phase 2 MELAS Data, Backs Weight-Based Dosing for Lead Mitochondrial Drug
14d ago
Thiogenesis to Present Late-Breaking Phase 2 MELAS Data on TTI-0102 at Mitocon 2026
PremiumCompany Announcements
Thiogenesis to Present Late-Breaking Phase 2 MELAS Data on TTI-0102 at Mitocon 2026
24d ago
Thiogenesis to Showcase Mitochondrial Disease Clinical Progress at UMDF Webinar
PremiumCompany Announcements
Thiogenesis to Showcase Mitochondrial Disease Clinical Progress at UMDF Webinar
1M ago
Thiogenesis Therapeutics Announces Phase 3 Trial for Innovative Cystinosis Treatment
PremiumCompany Announcements
Thiogenesis Therapeutics Announces Phase 3 Trial for Innovative Cystinosis Treatment
2M ago
Thiogenesis Reports Positive Interim Results and Pipeline Advancements
PremiumCompany AnnouncementsThiogenesis Reports Positive Interim Results and Pipeline Advancements
3M ago
Thiogenesis Therapeutics Advances in MELAS Treatment with TTI-0102 Study
Premium
Company Announcements
Thiogenesis Therapeutics Advances in MELAS Treatment with TTI-0102 Study
3M ago
TTI
Thiogenesis Therapeutics Advances LSS Treatment with New TTI-0102 Study
Premium
Company Announcements
Thiogenesis Therapeutics Advances LSS Treatment with New TTI-0102 Study
3M ago
TTI
Thiogenesis Extends Investor Relations Agreement with Capital Analytica
PremiumCompany Announcements
Thiogenesis Extends Investor Relations Agreement with Capital Analytica
4M ago
Thiogenesis Therapeutics Reports AGM Results and Corporate Milestones
PremiumCompany Announcements
Thiogenesis Therapeutics Reports AGM Results and Corporate Milestones
5M ago
Thiogenesis Therapeutics Corp Secures Over C$4.14 Million in Private Placement
PremiumCompany Announcements
Thiogenesis Therapeutics Corp Secures Over C$4.14 Million in Private Placement
6M ago
Thiogenesis Upsizes Private Placement Amid Strong Demand
PremiumCompany Announcements
Thiogenesis Upsizes Private Placement Amid Strong Demand
6M ago
Thiogenesis Therapeutics Announces $1.5 Million Private Placement to Fund Clinical Trials
PremiumCompany AnnouncementsThiogenesis Therapeutics Announces $1.5 Million Private Placement to Fund Clinical Trials
7M ago
Thiogenesis Advances Pediatric MASH Trial and Secures EU Patent
Premium
Company Announcements
Thiogenesis Advances Pediatric MASH Trial and Secures EU Patent
8M ago
Thiogenesis to Showcase Promising Mitochondrial Treatments at UMDF Conference
Premium
Company Announcements
Thiogenesis to Showcase Promising Mitochondrial Treatments at UMDF Conference
8M ago
Thiogenesis Expands Phase 2 MELAS Trial with New French Site
PremiumCompany Announcements
Thiogenesis Expands Phase 2 MELAS Trial with New French Site
8M ago
Thiogenesis Therapeutics Grants Stock Options to Directors
PremiumCompany Announcements
Thiogenesis Therapeutics Grants Stock Options to Directors
8M ago
Thiogenesis Receives FDA Clearance for Phase 2a Trial in Leigh Syndrome
PremiumCompany Announcements
Thiogenesis Receives FDA Clearance for Phase 2a Trial in Leigh Syndrome
8M ago
Thiogenesis Launches Phase 2 Trial for MELAS Treatment
PremiumCompany Announcements
Thiogenesis Launches Phase 2 Trial for MELAS Treatment
9M ago
Thiogenesis Expands European Reach with New Consultancy Agreement
PremiumCompany AnnouncementsThiogenesis Expands European Reach with New Consultancy Agreement
12M ago
Thiogenesis Therapeutics Begins OTCQX Trading and Prepares for Phase 2 Trial
Premium
Company Announcements
Thiogenesis Therapeutics Begins OTCQX Trading and Prepares for Phase 2 Trial
12M ago
Thiogenesis to Launch Phase 2 Trial for MELAS Treatment
Premium
Company Announcements
Thiogenesis to Launch Phase 2 Trial for MELAS Treatment
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >